guidelines:
  1: COVID-GRAM_Critical_Illness_Risk_Score_guideline.v1
test_cases:
- id: Low risk group Risk 0.8%
  input:
    1:
      gt0003|Age: 30,a
      gt0005|X-ray abnormality: 0|local::at0005|No|
      gt0006|Hemoptysis: 0|local::at0008|No|
      gt0007|Dyspnea: 0|local::at0011|No|
      gt0008|Unconsciousness: 0|local::at0014|No|
      gt0009|Number of comorbidities: 0|local::at0036|0|
      gt0010|Cancer history: 0|local::at0023|No|
      gt0011|Neutrophil-lymphocyte ratio (NLR): 2,1
      gt0012|Lactate dehydrogenase: 60,u/l
      gt0014|Direct Bilirubin, umol/l: 5,umol/l
      gt0017|Is this a COVID-19 patient?: local::at0029|Confirmed positive|
  expected_output:
    1:
      gt0021|Risk group: Low
      gt0019|COVID-GRAM Risk Score: 39.0,1
      gt0020|Risk of critical illness: 0.8,%
- id: Low risk group Risk 1.6%
  input:
    1:
      gt0003|Age: 40,a
      gt0005|X-ray abnormality: 0|local::at0005|No|
      gt0006|Hemoptysis: 0|local::at0008|No|
      gt0007|Dyspnea: 0|local::at0011|No|
      gt0008|Unconsciousness: 0|local::at0014|No|
      gt0009|Number of comorbidities: 1|local::at0017|1|
      gt0010|Cancer history: 0|local::at0023|No|
      gt0011|Neutrophil-lymphocyte ratio (NLR): 2,1
      gt0012|Lactate dehydrogenase: 60,u/l
      gt0014|Direct Bilirubin, umol/l: 5,umol/l
      gt0017|Is this a COVID-19 patient?: local::at0029|Confirmed positive|
  expected_output:
    1:
      gt0021|Risk group: Low
      gt0019|COVID-GRAM Risk Score: 56.0,1
      gt0020|Risk of critical illness: 1.6,%
- id: Medium risk group Risk 1.7%
  input:
    1:
      gt0003|Age: 42,a
      gt0005|X-ray abnormality: 0|local::at0005|No|
      gt0006|Hemoptysis: 0|local::at0008|No|
      gt0007|Dyspnea: 0|local::at0011|No|
      gt0008|Unconsciousness: 0|local::at0014|No|
      gt0009|Number of comorbidities: 1|local::at0017|1|
      gt0010|Cancer history: 0|local::at0023|No|
      gt0011|Neutrophil-lymphocyte ratio (NLR): 2,1
      gt0012|Lactate dehydrogenase: 60,u/l
      gt0014|Direct Bilirubin, umol/l: 5,umol/l
      gt0017|Is this a COVID-19 patient?: local::at0029|Confirmed positive|
  expected_output:
    1:
      gt0021|Risk group: Medium
      gt0019|COVID-GRAM Risk Score: 57.0,1
      gt0020|Risk of critical illness: 1.7,%
- id: Medium risk group Risk 41.4%
  input:
    1:
      gt0003|Age: 60,a
      gt0005|X-ray abnormality: 1|local::at0006|Yes|
      gt0006|Hemoptysis: 1|local::at0009|Yes|
      gt0007|Dyspnea: 0|local::at0011|No|
      gt0008|Unconsciousness: 0|local::at0014|No|
      gt0009|Number of comorbidities: 2|local::at0018|2|
      gt0010|Cancer history: 0|local::at0023|No|
      gt0011|Neutrophil-lymphocyte ratio (NLR): 2,1
      gt0012|Lactate dehydrogenase: 60,u/l
      gt0014|Direct Bilirubin, umol/l: 5,umol/l
      gt0017|Is this a COVID-19 patient?: local::at0029|Confirmed positive|
  expected_output:
    1:
      gt0021|Risk group: High
      gt0019|COVID-GRAM Risk Score: 139.0,1
      gt0020|Risk of critical illness: 41.4,%
- id: High risk group Risk 44.8%
  input:
    1:
      gt0003|Age: 65,a
      gt0005|X-ray abnormality: 1|local::at0006|Yes|
      gt0006|Hemoptysis: 1|local::at0009|Yes|
      gt0007|Dyspnea: 0|local::at0011|No|
      gt0008|Unconsciousness: 0|local::at0014|No|
      gt0009|Number of comorbidities: 2|local::at0018|2|
      gt0010|Cancer history: 0|local::at0023|No|
      gt0011|Neutrophil-lymphocyte ratio (NLR): 2,1
      gt0012|Lactate dehydrogenase: 60,u/l
      gt0014|Direct Bilirubin, umol/l: 5,umol/l
      gt0017|Is this a COVID-19 patient?: local::at0029|Confirmed positive|
  expected_output:
    1:
      gt0021|Risk group: High
      gt0019|COVID-GRAM Risk Score: 142.0,1
      gt0020|Risk of critical illness: 44.8,%
